US2016235695A1PendingUtilityA1

Combination composition

52
Assignee: AFT PHARMACEUTICALS LTDPriority: Nov 4, 2010Filed: Aug 21, 2015Published: Aug 18, 2016
Est. expiryNov 4, 2030(~4.3 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 25/20A61P 29/00A61P 25/04A61K 31/167A61K 9/0019A61K 47/183A61K 9/08A61K 31/192
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An intravenous composition for providing relief for pain and/or inflammation, the composition having ibuprofen and paracetamol in combination for delivering to a human at each dose: a) approximately 125 mg to approximately 175 mg ibuprofen in combination with approximately 475 mg to approximately 525 mg paracetamol; or b) approximately 275 mg to approximately 325 mg ibuprofen in combination with approximately 975 mg to approximately 1,025 mg paracetamol.

Claims

exact text as granted — not AI-modified
1 . An intravenous composition for providing relief for pain and/or inflammation, the composition having ibuprofen and paracetamol in combination for delivering to a human at each dose:
 a) approximately 125 mg to approximately 175 mg ibuprofen in combination with approximately 475 mg to approximately 525 mg paracetamol; or   b) approximately 275 mg to approximately 325 mg ibuprofen in combination with approximately 975 mg to approximately 1,025 mg paracetamol.   
     
     
         2 . A composition according to  claim 1 , for dosing on approximately a 6 hourly basis. 
     
     
         3 . A composition according to  claim 1  or  2 , comprising:
 a) approximately 150 mg ibuprofen in combination with approximately 500 mg paracetamol; or 
 b) approximately 300 mg ibuprofen in combination with approximately 1,000 mg paracetamol. 
 
     
     
         4 . A composition according to  claim 1 ,  2  or  3 , in the form of a solution. 
     
     
         5 . The use of paracetamol and ibuprofen in the manufacture of an intravenous medicament for treating pain and/or inflammation in a human wherein the medicament comprises, on a per dose basis:
 a) approximately 125 mg to approximately 175 mg ibuprofen in combination with approximately 475 mg to approximately 525 mg paracetamol; or   b) approximately 275 mg to approximately 325 mg ibuprofen in combination with approximately 975 mg to approximately 1,025 mg paracetamol.   
     
     
         6 . A use according to  claim 5 , wherein the composition is for dosing on approximately a 6 hourly basis 
     
     
         7 . A use according to  claim 5  or  6 , wherein the composition comprises:
 a) approximately 150 mg ibuprofen in combination with approximately 500 mg paracetamol; or 
 b) approximately 300 mg ibuprofen in combination with approximately 1,000 mg paracetamol. 
 
     
     
         8 . A use according to  claim 5 ,  6  or  7 , wherein the composition is in the form of a solution. 
     
     
         9 . A method of treating pain and/or inflammation by administering to a human, intravenously, a medicament comprising:
 a) approximately 125 mg to approximately 175 mg ibuprofen in combination with approximately 475 mg to approximately 525 mg paracetamol; or   b) approximately 275 mg to approximately 325 mg ibuprofen in combination with approximately 975 mg to approximately 1,025 mg paracetamol.   
     
     
         10 . A method according to  claim 9 , wherein the composition is administered on a 6 hourly basis. 
     
     
         11 . A method according to  claim 9  or  10 , wherein the composition comprises:
 a) approximately 150 mg ibuprofen in combination with approximately 500 mg paracetamol; or 
 b) approximately 300 mg ibuprofen in combination with approximately 1,000 mg paracetamol.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.